InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,230.80
(
-0.15%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
-0.72%
)
Bitcoin
64,108.74
(
-1.10%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

ECole

Send PM Follow Ignore
Followers 21
Posts 1331
Boards Moderated 1
Alias Born 07/02/2013

ECole

Re: None

Monday, 09/30/2013 10:57:14 AM

Monday, September 30, 2013 10:57:14 AM

Post# of 80490
Conf call transcript

review the clinical data presented at the 2013 Congress of the European Society for Medical Oncology as well, from on going Phase 1/2 study of our investigational tyrosine kinase inhibitor AP26113 in patients with advanced non-small lung cancer




http://www.earningsimpact.com/Transcript/83879/ARIA/Ariad-Pharmaceuticals%2c-Inc----Business-Update-Call

I record my personal, subjective observations about the markets, solely for my entertainment and that of interested readers and to foster research. Nothing should be construed as financial advice or an offer or recommendation to purchase or sell any secur

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up